RESEARCH TRIANGLE PARK, N.C. – October 26, 2007 – Quintiles Transnational Corp. today announced that Christopher H. Cabell, M.D., MHS, FACC, an expert cardiologist and clinical investigator, has joined the Medical & Scientific Services group in Global Clinical Development Services (CDS). In addition to his CDS work, he provides U.S.-based cardiology expertise for Quintiles ECG Services.
Cabell comes to Quintiles from the Duke University School of Medicine, where he developed a strong background in cardiac safety. He held several appointments within the Duke Clinical Research Institute (DCRI), including Co-Chair and Principal Investigator for a Duke/FDA Cardiac Safety partnership to develop a new generation of tools to identify the potential effects of medical devices and drugs on the heart. Also within DCRI, he held appointments as Director of the Echocardiography Core Laboratory, Associate Director of the ECG Core Laboratory and Director of the International Collaboration on Endocarditis. He also was Assistant Professor of Medicine in the Division of Cardiology.
“As a cardiac safety expert and experienced clinical investigator, Chris will be an important contributor to our customers’ efforts to bring safer and more effective medicines to the public,” said David Frakes, M.D., Global Vice President, Medical & Scientific Services. “It is essential to identify the potential effects of drugs on the cardiovascular system as early as possible in clinical research. Chris is a significant addition to the expertise of our Medical and Scientific Services team.”
Ferzaan Engineer, CEO of Quintiles India and head of Quintiles Technologies (India), said Cabell’s support of ECG Services would be of particular interest to U.S.-based customers who rely on Quintiles for round-the-clock analysis of electrocardiograms. “His work at the ECG Laboratory at Duke along with his clinical experience adds depth and breadth to our ECG Services team.”
Cabell’s responsibilities include serving as a medical advisor on clinical project teams and providing support to investigative sites and project staff regarding protocol issues. He is based at the Quintiles offices near Research Triangle Park, North Carolina.
Cabell has authored or co-authored 50 articles for peer-reviewed publications and delivered more than 30 invited lectures. He is a member of several professional organizations, a Fellow of the American College of Cardiology, and a reviewer for a number of medical journals, including the Journal of the American Medical Association. He earned his medical degree and a Master’s in Health Science from the Duke University School of Medicine.
Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the pharmaceutical, biotechnology and healthcare industries. With more than 19,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company’s Web site at www.quintiles.com.